Clinical Trial Update: Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP) [Phase 1, Phase 2]

View source ↗

Summary

This phase 1/2 trial evaluated carfilzomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Nantes University Hospital | Conditions: Myeloma | Phase 1, Phase 2 | Status: COMPLETED